HYKK and squamous cell lung carcinoma: Lastly, by leveraging comprehensive gene expression datasets, we adopted a stringent selection process to evaluate actionable drug targets and uncovered HYKK (AGPHD1) as a treatment target associated with the risk of lung squamous cell carcinoma.